Arama Sonuçları - Yohei Maeshima
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 20
-
1
Angiogenesis and chronic kidney disease Yazar: Yohei Maeshima, Hirofumi Makino
Baskı/Yayın Bilgisi 2010Artigo -
2
Renal Fibrosis Yazar: Michael Zeisberg, Yohei Maeshima, Barbara Mosterman, Raghu Kalluri
Baskı/Yayın Bilgisi 2002Artigo -
3
Antiangiogenic Therapy for Diabetic Nephropathy Yazar: Katsuyuki Tanabe, Yohei Maeshima, Yasufumi Sato, Jun Wada
Baskı/Yayın Bilgisi 2017Revisão -
4
Renal Fibrosis Yazar: Michael Zeisberg, Gary D. Bonner, Yohei Maeshima, Pablo Colorado, G. Müller, Frank Strutz, Raghu Kalluri
Baskı/Yayın Bilgisi 2001Artigo -
5
-
6
Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy Yazar: Yoshihiko Yamamoto, Yohei Maeshima, Hiroyuki Kitayama, Shinji Kitamura, Yuki Takazawa, Hitoshi Sugiyama, Yasushi Yamasaki, Hirofumi Makino
Baskı/Yayın Bilgisi 2004Artigo -
7
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity Yazar: Hans Petter Eikesdal, Hikaru Sugimoto, Gabriel Birrane, Yohei Maeshima, Vesselina G. Cooke, Mark W. Kieran, Raghu Kalluri
Baskı/Yayın Bilgisi 2008Artigo -
8
Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin Yazar: Yohei Maeshima, Mark Manfredi, Corinne Reimer, Kathryn A. Holthaus, Helmut Hopfer, Babi R. Chandamuri, Surender Kharbanda, Raghu Kalluri
Baskı/Yayın Bilgisi 2001Artigo -
9
Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model Yazar: Katsuyuki Tanabe, Yohei Maeshima, Kunihiro Ichinose, Hiroyuki Kitayama, Yuki Takazawa, Kumiko Hirokoshi, Masaru Kinomura, Hitoshi Sugiyama, Hirofumi Makino
Baskı/Yayın Bilgisi 2006Artigo -
10
Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. Yazar: Yohei Maeshima, Naoki Kashihara, Tatsuji Yasuda, Hitoshi Sugiyama, T. Sekikawa, Ken Okamoto, Koichiro Kanao, Yasuko Watanabe, Yashpal S. Kanwar, Hirofumi Makino
Baskı/Yayın Bilgisi 1998Artigo -
11
Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy Yazar: Tatsuyo Nasu, Yohei Maeshima, Masaru Kinomura, Kumiko Hirokoshi-Kawahara, Katsuyuki Tanabe, Hitoshi Sugiyama, Hikaru Sonoda, Yasufumi Sato, Hirofumi Makino
Baskı/Yayın Bilgisi 2009Artigo -
12
Antiangiogenic Endostatin Peptide Ameliorates Renal Alterations in the Early Stage of a Type 1 Diabetic Nephropathy Model Yazar: Kunihiro Ichinose, Yohei Maeshima, Yoshihiko Yamamoto, Hiroyuki Kitayama, Yuki Takazawa, Kumiko Hirokoshi, Hitoshi Sugiyama, Yasushi Yamasaki, Katsumi Eguchi, Hirofumi Makino
Baskı/Yayın Bilgisi 2005Artigo -
13
Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice Yazar: Mizuho Kobayashi, Hitoshi Sugiyama, Da-Hong Wang, Toda Naomi, Yohei Maeshima, Yasushi Yamasaki, Noriyoshi Masuoka, Masao Yamada, Shohei Kira, Hirofumi Makino
Baskı/Yayın Bilgisi 2005Artigo -
14
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin Yazar: Yuki Hamano, Michael Zeisberg, Hikaru Sugimoto, Julie C. Lively, Yohei Maeshima, Changqing Yang, Richard O. Hynes, Zena Werb, Akulapalli Sudhakar, Raghu Kalluri
Baskı/Yayın Bilgisi 2003Artigo -
15
2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice Yazar: Kunihiro Ichinose, Yohei Maeshima, Yoshihiko Yamamoto, Masaru Kinomura, Kumiko Hirokoshi, Hiroyuki Kitayama, Yuki Takazawa, Hitoshi Sugiyama, Yasushi Yamasaki, Naoki Agata, Hirofumi Makino
Baskı/Yayın Bilgisi 2006Artigo -
16
Extracellular Matrix-derived Peptide Binds to αvβ3 Integrin and Inhibits Angiogenesis Yazar: Yohei Maeshima, Udaya Yerramalla, Mohanraj Dhanabal, Kathryn A. Holthaus, Sergei F. Barbashov, Surender Kharbanda, Corinne Reimer, Mark Manfredi, W. Matthew Dickerson, Raghu Kalluri
Baskı/Yayın Bilgisi 2001Artigo -
17
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy Yazar: Katsuyuki Tanabe, Yoshifuru Tamura, Miguel A. Lanaspa, Makoto Miyazaki, Norihiko Suzuki, Waichi Sato, Yohei Maeshima, George F. Schreiner, Francisco Villarreal, Richard J. Johnson, Takahiko Nakagawa
Baskı/Yayın Bilgisi 2012Artigo -
18
Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane Yazar: Yohei Maeshima, Pablo Colorado, Adriana de la Torre, Kathryn A. Holthaus, James A. Grunkemeyer, Mark B. Ericksen, Helmut Hopfer, Yingwen Xiao, Isaac E. Stillman, Raghu Kalluri
Baskı/Yayın Bilgisi 2000Artigo -
19
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth Yazar: George D. Kamphaus, Pablo Colorado, David J. Panka, Helmut Hopfer, Ramani Ramchandran, Adriana de la Torre, Yohei Maeshima, James W. Mier, Vikas P. Sukhatme, Raghu Kalluri
Baskı/Yayın Bilgisi 2000Artigo -
20
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease Yazar: Masashi Kitagawa, Hitoshi Sugiyama, Hiroshi Morinaga, Tatsuyuki Inoue, Keiichi Takiue, Ayu Ogawa, Toshio Yamanari, Yoko Kikumoto, Haruhito A. Uchida, Shinji Kitamura, Yohei Maeshima, Kazufumi Nakamura, Hiroshi Ito, Hirofumi Makino
Baskı/Yayın Bilgisi 2013Artigo
Arama Araçları:
İlgili Konular
Angiogenesis
Medicine
Biology
Internal medicine
Chemistry
Endocrinology
Biochemistry
Cancer research
Cell biology
Kidney
Basement membrane
Diabetes mellitus
Diabetic nephropathy
Extracellular matrix
Cell
Endostatin
Laminin
Nephropathy
Type IV collagen
VEGF receptors
Vascular endothelial growth factor
Biotechnology
Fibrosis
In vitro
In vivo
Molecular biology
Cell growth
Endothelial stem cell
Integrin
Kidney disease